Citadel Advisors’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-33,766
Closed -$268K 14483
2025
Q2
$268K Buy
+33,766
New +$151K ﹤0.01% 10054
2025
Q1
Sell
-1,507,192
Closed -$2.56M 15809
2024
Q4
$2.56M Buy
1,507,192
+64,724
+4% +$191K ﹤0.01% 5131
2024
Q3
$4.9M Sell
1,442,468
-691
-0% -$2.56K 0.01% 3980
2024
Q2
$5.77M Sell
1,443,159
-722,652
-33% -$2.47M 0.01% 3526
2024
Q1
$7.39M Buy
2,165,811
+3,909
+0.2% +$12.2K 0.01% 3366
2023
Q4
$7.31M Sell
2,161,902
-4,211
-0.2% -$21.7K 0.01% 3259
2023
Q3
$11.7M Sell
2,166,113
-14,211
-0.7% -$98.2K 0.01% 2488
2023
Q2
$20.5M Buy
2,180,324
+18,528
+0.9% +$175K 0.02% 1851
2023
Q1
$21.2M Sell
2,161,796
-2,120
-0.1% -$23.8K 0.02% 1865
2022
Q4
$27M Sell
2,163,916
-2,551
-0.1% -$31.3K 0.03% 1650
2022
Q3
$19.7M Buy
2,166,467
+1,431
+0.1% +$10.5K 0.02% 1889
2022
Q2
$5.47M Buy
2,165,036
+2,397
+0.1% +$9.47K 0.01% 3629
2022
Q1
$14.9M Buy
+2,162,639
New +$28.5M 0.02% 2379

Other funds holding VIGL